Every engagement has a defined scope, a clear output, and a senior point of contact throughout. No junior consultants. No generalist advice. Just execution.
We actively scan the European generics and specialty pharma market for in-licensing opportunities that match your portfolio criteria. Every month you receive a structured opportunity report — shortlisted, scored, and ready to act on.
We handle the initial partner outreach, so you only engage when there's a real opportunity on the table.
What you get
- Monthly opportunity report with 3–8 shortlisted products
- Commercial pre-screening (market size, competition, pricing)
- Regulatory risk assessment (MA status, dossier type, timeline)
- Patent and SPC screening across target markets
- Initial partner outreach and NDA/CDA handling
You have a product with an existing EU Marketing Authorisation. We build and execute the full Nordic market entry — from regulatory pathway through distributor selection, pricing strategy and channel launch.
One senior contact. Defined milestones. No surprises.
What you get
- Full Nordic regulatory strategy (DK, SE, NO, FI)
- MRP/DCP or national procedure management
- Distributor and partner identification and onboarding
- Pricing strategy and reimbursement approach per country
- Launch plan with KPIs, timeline and channel setup
- Ongoing advisory through first 6 months of sales
You've found a product, asset or potential partner. Before you commit time and legal fees, you need a clear read on the commercial and regulatory reality. That's what we deliver — fast.
We assess the opportunity across four dimensions and give you a structured recommendation with supporting data. No fluff. No hedging.
What you get
- Market size and competitive landscape analysis
- Regulatory pathway assessment (MA status, dossier quality)
- Supply chain and CMO risk review
- Patent and SPC expiry analysis per market
- Clear go/no-go recommendation with scoring matrix
Not sure which fits?
Book a 30-minute call. We'll figure it out together — at no cost.